Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 245
 
About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Advertise Login 
     
ORIGINAL ARTICLE
Year : 2021  |  Volume : 10  |  Issue : 3  |  Page : 192-198

Evaluation of cachectin level in preterm neonates as an indicator of necrotizing enterocolitis


Department of Pediatrics, Faculty of Medicine, Suez Canal University, Ismailia, Egypt

Correspondence Address:
Abdelmoneim Khashana
Associate professor of Pediatrics and Neonatology, Pediatrics and Neonatology, Faculty of Medicine, Suez Canal University, Ismailia
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jcn.jcn_166_20

Rights and Permissions

Background: Necrotizing enterocolitis (NEC) is an inflammatory disorder that affects the gastrointestinal system of the preterm infants (gestational age less than 37 weeks). Cachectin is a cell signaling protein (cytokine) involved in systemic inflammation and is one of the cytokines that make up the acute phase reaction. Aim: To evaluate the level of blood cachectin (TNF-α) in preterm neonates as an indicator for NEC. Material and Methods: The present study was designed as an analytical cross-sectional study that included two groups: i) preterm neonates with necrotizing enterocolitis (NEC) admitted at neonatal intensive care unit (NICU) in Suez Canal University Hospital (n = 25), and ii) healthy preterm neonates (n = 25) who served as a normal control group. All neonates subjected to prenatal, natal and postnatal history, Physical examination, and blood samples were taken from cases once diagnosed as suspected NEC, proven NEC, or advanced NEC and from healthy preterm neonates when taking full oral feeding as a control. Then, measurement of cachectin level was done by ELISA kits. Results: It was found that neonates with necrotizing enterocolitis had significantly higher cachectin level (365.91 ± 260.76 ng/L) than healthy controls (83.92 ± 44.01 ng/L) (P < 0.001) and was also found that cachectin (TNF-α) levels are higher in NEC patients with complications. It was also found that cachectin (TNF-α) level of 116.6 was the best cut-off points with sensitivity of 92% and specificity of 90% for prediction of NEC among preterm neonates. Conclusion: The level of serum cachectin is higher in neonates with NEC than in healthy preterm neonates and it can be used as an indicator for early diagnosis of NEC.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed734    
    Printed20    
    Emailed0    
    PDF Downloaded68    
    Comments [Add]    

Recommend this journal